These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32748868)

  • 21. Role of K+ channel activators in cardiac electrophysiology and arrhythmias.
    Antzelevitch C; Di Diego JM
    Circulation; 1992 Apr; 85(4):1627-9. PubMed ID: 1555302
    [No Abstract]   [Full Text] [Related]  

  • 22. Metformin restores electrophysiology of small conductance calcium-activated potassium channels in the atrium of GK diabetic rats.
    Fu X; Pan Y; Cao Q; Li B; Wang S; Du H; Duan N; Li X
    BMC Cardiovasc Disord; 2018 Apr; 18(1):63. PubMed ID: 29636010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Potassium channels and arrhythmia].
    Funck-Brentano C
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():9-13. PubMed ID: 1307198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific inhibition of HCN channels slows rhythm differently in atria, ventricle and outflow tract and stabilizes conduction in the anoxic-reoxygenated embryonic heart model.
    Sarre A; Pedretti S; Gardier S; Raddatz E
    Pharmacol Res; 2010 Jan; 61(1):85-91. PubMed ID: 19818405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Na
    Pabel S; Ahmad S; Tirilomis P; Stehle T; Mustroph J; Knierim M; Dybkova N; Bengel P; Holzamer A; Hilker M; Streckfuss-Bömeke K; Hasenfuss G; Maier LS; Sossalla S
    Basic Res Cardiol; 2020 Feb; 115(2):20. PubMed ID: 32078054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the mechanism of action of antiarrhythmic agents.
    Grant AO
    Am Heart J; 1992 Apr; 123(4 Pt 2):1130-6. PubMed ID: 1313200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on antiarrhythmic drug pharmacology.
    Huang CL; Wu L; Jeevaratnam K; Lei M
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):579-592. PubMed ID: 31930579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antiarrhythmics on the electrical restitution in perfused guinea-pig heart are critically determined by the applied cardiac pacing protocol.
    Osadchii OE
    Exp Physiol; 2019 Apr; 104(4):490-504. PubMed ID: 30758086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic agents: current status and perspectives.
    Mátyus P; Varró A; Papp JG; Wamhoff H; Varga I; Virág L
    Med Res Rev; 1997 Sep; 17(5):427-51. PubMed ID: 9276860
    [No Abstract]   [Full Text] [Related]  

  • 30. Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
    Iskit AB; Erkent U; Ertunc M; Guc MO; Ilhan M; Onur R
    Vascul Pharmacol; 2007 Feb; 46(2):129-36. PubMed ID: 17064967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiologic changes in heart failure: focus on pacemaker channels.
    Sartiani L; Stillitano F; Cerbai E; Mugelli A
    Can J Physiol Pharmacol; 2009 Feb; 87(2):84-90. PubMed ID: 19234571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management.
    Thomas D; Christ T; Fabritz L; Goette A; Hammwöhner M; Heijman J; Kockskämper J; Linz D; Odening KE; Schweizer PA; Wakili R; Voigt N
    Clin Res Cardiol; 2019 Jun; 108(6):577-599. PubMed ID: 30306295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of physiological late Na
    El-Bizri N; Li CH; Liu GX; Rajamani S; Belardinelli L
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H236-H245. PubMed ID: 28971840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiarrhythmic effect of the antiopioid peptide nociceptin and its effect on fast Na+-channels in cardiomyocytes].
    Lishmanov IuB; Krylatov AV; Maslov LN
    Biull Eksp Biol Med; 1998 Dec; 126(12):655-7. PubMed ID: 9934512
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiac arrhythmogenesis: a tale of two clocks?
    Lei M; Huang CL
    Cardiovasc Res; 2020 Dec; 116(14):e205-e209. PubMed ID: 31800017
    [No Abstract]   [Full Text] [Related]  

  • 37. Valsartan reduced the vulnerability to atrial fibrillation by preventing action potential prolongation and conduction slowing in castrated male mice.
    Sun YL; Li PH; Shi L; Su WZ; Li DS; Xue GL; Zhao Y; Li CZ; Li Y; Zhou Y; Li SX; Zhang Y; Lu YJ; Pan ZW
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1436-1443. PubMed ID: 30016000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is ranolazine an antiarrhythmic drug?
    Eckhardt LL; Teelin TC; January CT
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H1989-91. PubMed ID: 18375723
    [No Abstract]   [Full Text] [Related]  

  • 39. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
    Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Varró A; Szénási G; Nánási PP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular electrophysiological effects of botulinum toxin A on neonatal rat cardiomyocytes and on cardiomyocytes derived from human-induced pluripotent stem cells.
    Nizamieva A; Frolova S; Slotvitsky M; Kovalenko S; Tsvelaya V; Nikitina A; Sergeevichev D; Agladze K
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Mar; 396(3):513-524. PubMed ID: 36399184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.